TACI Mutations in Primary Antibody Deficiencies: A Nationwide Study in Greece

• Main Authors: Ioannis Kakkas, Gerasimina Tsinti, Fani Kalala, Evangelia Farmaki, Alexandra Kourakli, Androniki Kapousouzi, Maria Dimou, Vassiliki Kalaitzidou, Eirini Sevdali, Athanasia-Marina Peristeri, Georgia Tsiouma, Peristera Patiou, Eleni Papadimitriou, Theodoros P. Vassilakopoulos, Panayiotis Panayiotidis, Anna Kioumi, Argiris Symeonidis, Matthaios Speletas
• Format: Article
• Language: English
• Published: MDPI AG 2021-08-01
• Series: Medicina
• Subjects: TACI; CVID; autoimmune cytopenias; benign lymphoproliferation
• Online Access: https://www.mdpi.com/1648-9144/57/8/827

<i>Background and objectives</i>: Monoallelic (heterozygous) or biallelic (homozygous or compound heterozygous) TACI mutations have been reported as the most common genetic defects in patients with common variable immunodeficiency (CVID), which is the most common clinically significant primary immunodeficiency in humans. The aim of our study was to evaluate the prevalence and any correlations of TACI defects in Greek patients with primary antibody deficiencies. <i>Materials and Methods</i>: 117 patients (male/female: 53/64) with CVID (110) and a combined IgA and IgG subclass deficiency (7) with a CVID-like clinical phenotype were enrolled in the study. Genomic DNA was extracted from peripheral blood and the molecular analysis of the <i>TACI</i> gene was performed by PCR (Polymerase Chain Reaction) and sequencing of all 5 exons, including exon–intron boundaries. <i>Results</i>: Seventeen patients (14.5%) displayed TACI defects, four (23.5%) carried combined heterozygous mutations and 13 (76.5%) carried single heterozygous mutations. The most frequently detected mutation was C104R (58.8%), followed by I87N (23.5%) and A181E (11.8%), while R20C, C62Y, P151L, K188M and E236X mutations were present in only one patient each. Patients with TACI defects were more frequently male (<i>p</i> = 0.011) and displayed a benign lymphoproliferation (splenomegaly and lymph node enlargement, <i>p</i> = 0.047 and <i>p</i> = 0.002, respectively), had a history of tonsillectomy (<i>p</i> = 0.015) and adenoidectomy (<i>p</i> = 0.031) and more frequently exhibited autoimmune cytopenias (<i>p</i> = 0.046). <i>Conclusions</i>: Considering that accumulating evidence suggests several CVID patients have a complex rather than a monogenic inheritance, our data further support the notion that TACI mutations, particularly as monoallelic defects, should be primarily considered as susceptibility co-factors and/or modifiers of primary antibody deficiencies.